9. 8. 96 Official Journal of the European Communities No L 201/1 II (Acts whose publication is not obligatory) COMMISSION COMMISSION DECISION of 10 January 1996 relating to a proceeding under Article 85 of the EC Treaty (Case IV/34.279/F3 — ADALAT) {Only the German text is authentic) (96/478/EC) CONTENTS OF THE DECISION CHAPTER ] THE FACTS Section I The product 1. Nature of the product 2. Markets on which ADALAT is sold 2.1. Coronary heart disease 2.2. Hypertension 2.3. Congestive heart failure 3. Importance of the product 3.1. A major product for Bayer a. For the group b. A major product in the sales strategies of Bayer subsidiaries in the various Member States 3.2. Market shares a. In France b. In Spain c. In the United Kingdom d. In the Community of Twelve e Conclusion